Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Mainga Hamaluba et al.|The Lancet|2024Cited by 345
A Phase III Randomised Controlled Trial Evaluating the Malaria Vaccine Candidate R21/Matrix-M™ in African ChildrenMehreen Datoo, Adrian V. S. Hill, Alassane Dicko et al.|SSRN Electronic Journal|2023Cited by 29